Teva Pharmaceutical Industries Limited Stock TEL AVIV STOCK EXCHANGE
Stocks
TEVA
IL0006290147
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9,265.00 ILa | -2.83% |
|
-8.45% | -8.18% |
| 06-18 | FDA Seeks Updated Labeling for Testosterone Therapies | MT |
| 06-18 | Teva Submits New Drug Application for Ecopipam to Treat Pediatric Tourette Syndrome | MT |
| Market Cap | 37.91B 11,160B 33.08B 30.49B 28.71B 53.59B 3,576B 54.03B 363B 141B 1,760B 142B 139B 6,113B | P/E 2026 * |
32.7x | P/E 2027 * | 17.6x |
|---|---|---|---|---|---|
| Enterprise Value | 48.95B 14,407B 42.7B 39.36B 37.07B 69.18B 4,617B 69.75B 468B 182B 2,272B 184B 180B 7,892B | EV / Sales 2026 * |
2.94x | EV / Sales 2027 * | 2.66x |
| Free-Float |
88.61% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Teva Pharmaceutical Industries Limited
| 1 day | -2.83% | ||
| 1 week | -8.45% | ||
| Current month | -5.84% | ||
| 1 month | -8.18% | ||
| 3 months | -1.34% | ||
| 6 months | -4.74% | ||
| Current year | -8.18% |
| 1 week | 9,250 |  | 10,230 |
| 1 month | 9,250 | | 10,240 |
| Current year | 8,860 | | 11,350 |
| 1 year | 5,305 | | 11,350 |
| 3 years | 2,687 | | 11,350 |
| 5 years | 2,383 | | 11,350 |
| 10 years | 2,175 | | 21,770 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 57 | 2022-12-31 |
Eli Kalif
DFI | Director of Finance/CFO | 53 | 2019-12-21 |
Matthew Shields
COO | Chief Operating Officer | 52 | 2024-06-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Amir Elstein
BRD | Director/Board Member | 69 | 2008-12-31 |
Sol Barer
CHM | Chairman | 78 | 2017-02-05 |
Rosemary Crane
BRD | Director/Board Member | 65 | 2015-08-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.83% | -8.45% | - | - | 37.91B | |
| -1.21% | -3.33% | +38.84% | +145.38% | 992B | |
| -2.48% | -4.23% | +49.88% | +39.07% | 564B | |
| -2.14% | -3.76% | +16.72% | +56.15% | 391B | |
| -1.18% | +0.68% | +24.66% | +16.53% | 330B | |
| -2.36% | -2.30% | +23.37% | +11.59% | 280B | |
| -2.45% | -0.84% | +23.51% | +30.06% | 279B | |
| -1.91% | -1.06% | -42.60% | -49.25% | 196B | |
| -1.19% | -0.04% | +16.39% | +47.00% | 184B | |
| -1.35% | +1.88% | +14.59% | +56.94% | 156B | |
| Average | -1.04% | +0.41% | +18.37% | +39.27% | 374.58B | |
| Weighted average by Cap. | -0.54% | -0.49% | +27.10% | +63.21% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.65B 4,901B 14.52B 13.39B 12.61B 23.53B 1,570B 23.73B 159B 61.82B 773B 62.49B 61.15B 2,684B | 17.26B 5,080B 15.06B 13.88B 13.07B 24.39B 1,628B 24.6B 165B 64.08B 801B 64.78B 63.39B 2,783B |
| Net income | 1.74B 511B 1.52B 1.4B 1.32B 2.45B 164B 2.48B 16.61B 6.45B 80.6B 6.52B 6.38B 280B | 2.72B 800B 2.37B 2.19B 2.06B 3.84B 257B 3.88B 26.01B 10.1B 126B 10.21B 9.99B 438B |
| Net Debt | 11.03B 3,247B 9.62B 8.87B 8.35B 15.59B 1,041B 15.72B 105B 40.96B 512B 41.4B 40.51B 1,779B | 8.01B 2,359B 6.99B 6.44B 6.07B 11.32B 756B 11.42B 76.62B 29.75B 372B 30.07B 29.43B 1,292B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-18 | 9,265.00 ILa | -2.83% | 1,141,221 |
| 26-06-17 | 9,535.00 ILa | -1.69% | 810,016 |
| 26-06-16 | 9,699.00 ILa | -2.52% | 904,000 |
| 26-06-15 | 9,950.00 ILa | -2.16% | 795,091 |
| 26-06-12 | 10,170.00 ILa | -0.10% | 281,971 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TEVA Stock
- TEVA Stock
Select your edition
All financial news and data tailored to specific country editions
